Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Simulations PlusSLP +0.11%86 Net Cash per Share is $1.78 as of May. 2026, which is 84% below its 10-year median of 11.34. GuruFocus rates SLP with a GF Score™ of 86/100 and a GF Value™ of $34.35 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 144 Healthcare Providers & Services companies, Simulations Plus ranks worse than 59.72% on this metric.
The historical rank and industry rank for Simulations Plus's Net Cash per Share or its related term are showing as below:
SLP'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 6.8 Med: 11.34 Max: 1025.5
Current: 10.29
During the past 13 years, the highest Price-to-Net-Cash Ratio of Simulations Plus was 1025.50. The lowest was 6.80. And the median was 11.34.
SLP's Price-to-Net-Cash is ranked worse than 59.72% of 144
companies
in the Healthcare Providers & Services industry
Industry Median: 8.14
vs SLP: 10.29
Simulations Plus (NAS:SLP) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Simulations Plus Net Cash per Share Related Terms
Simulations Plus Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Simulations Plus's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SLP vs CTEV, TBRG, CARL: Net Cash per Share Comparison
For the Health Information Services subindustry, Simulations Plus's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simulations Plus Price-to-Net-Cash vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Simulations Plus's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Simulations Plus's Net Cash per Share for the fiscal year that ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simulations Plus (SLP) has a Net Cash per Share of $1.78 as of May. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Simulations Plus and its competitors. This is 84% below median its historical median of 11.34. Over the past decade, Simulations Plus' Net Cash per Share has ranged from 6.80 to 1,025.50. According to the industry distribution chart, Simulations Plus ranks #86 out of 144 companies in the Healthcare Providers & Services industry, placing it in the top 59.7%.
Is Simulations Plus' Net Cash per Share too high?
Simulations Plus' current Net Cash per Share of $1.78 is 84% below median its 10-year median of 11.34. Over the past 10 years, this metric has ranged from a low of 6.80 to a high of 1,025.50. The Healthcare Providers & Services industry median Net Cash per Share is 8.14. Simulations Plus' value of $1.78 is 78.1% below this industry median. Based on the distribution chart, Simulations Plus ranks #86 out of 144 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Simulations Plus has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' Net Cash per Share compare to CTEV and TBRG?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #86 out of 144 companies for Net Cash per Share. This places Simulations Plus in the lower half of its industry. The industry median Net Cash per Share is 8.14. Simulations Plus' value of $1.78 is 78.1% below this benchmark. Historically, Simulations Plus' own Net Cash per Share has ranged from 6.80 to 1,025.50 over the past decade. While the company's 10-year median is 11.34 vs. the industry median of 8.14, Simulations Plus has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Healthcare Providers & Services company?
The median Net Cash per Share among Healthcare Providers & Services companies is 8.14, based on 144 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simulations Plus's current Net Cash per Share of $1.78 is 78.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Simulations Plus and its competitors. For the Healthcare Providers & Services industry, the median Net Cash per Share is 8.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simulations Plus's current Net Cash per Share is $1.78, which is 84% below median its own 10-year median of 11.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (SLP) is currently considered Significantly Undervalued. The stock's GF Value™ is $34.35, compared to a current price of $18.32 — trading 46.7% below its estimated fair value. The current Net Cash per Share is $1.78, which is 84% below median its 10-year median of 11.34 and 78.1% below the Healthcare Providers & Services industry median of 8.14. Simulations Plus' overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Simulations Plus (SLP), the current Net Cash per Share is $1.78 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Simulations Plus (SLP) Overvalued in 2026?
Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued.
The current stock price of $18.32 is trading 46.7% below its estimated GF Value™ of $34.35.
GuruFocus considers Simulations Plus to be Significantly Undervalued.
Key valuation signals for SLP:
Net Cash per Share: $1.78 (84% below median its 10-year median of 11.34)
GF Value™: $34.35 vs. price of $18.32 (46.7% below fair value)
Industry Position: 78.1% below the Healthcare Providers & Services median (#86 of 144)
No single metric tells the full story. See the SLP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
86GF Score
Get the complete analysis for SLP
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SLP has been successfully added to your 
